# Filing Detail

Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001193125-22-018280
Filing Date
2022-01-26
Accepted
2022-01-26 16:05:58
Documents
10
Period of Report
2022-03-17

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | DEF 14A | d298856ddef14a.htm | DEF 14A | 928563
2 | GRAPHIC | g298856g01015.jpg | GRAPHIC | 252330
3 | GRAPHIC | g298856g01r22.jpg | GRAPHIC | 156711
4 | GRAPHIC | g298856g02w11.jpg | GRAPHIC | 224304
5 | GRAPHIC | g298856g03z11.jpg | GRAPHIC | 86131
6 | GRAPHIC | g298856g08m78.jpg | GRAPHIC | 50524
7 | GRAPHIC | g298856g20a36.jpg | GRAPHIC | 36491
8 | GRAPHIC | g298856g27e04.jpg | GRAPHIC | 54665
9 | GRAPHIC | g298856g57a00.jpg | GRAPHIC | 143345
10 | GRAPHIC | g298856g70d20.jpg | GRAPHIC | 68095
| Complete submission text file | 0001193125-22-018280.txt |  | 2408304

Mailing Address 177 E COLORADO BLVD SUITE 700 PASADENA CA 91105
Business Address 177 E COLORADO BLVD SUITE 700 PASADENA CA 91105 626-696-4702
ARROWHEAD PHARMACEUTICALS, INC. (Filer) CIK: 0000879407 (see all company filings)

EIN.: 460408024 | State of Incorp.: DE | Fiscal Year End: 0930
Type: DEF 14A | Act: 34 | File No.: 001-38042 | Film No.: 22557900
SIC: 2834 Pharmaceutical Preparations